Paul Erhardt

3.5k total citations
113 papers, 2.3k citations indexed

About

Paul Erhardt is a scholar working on Molecular Biology, Organic Chemistry and Spectroscopy. According to data from OpenAlex, Paul Erhardt has authored 113 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 45 papers in Organic Chemistry and 15 papers in Spectroscopy. Recurrent topics in Paul Erhardt's work include Chemical Synthesis and Analysis (12 papers), Analytical Chemistry and Chromatography (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Paul Erhardt is often cited by papers focused on Chemical Synthesis and Analysis (12 papers), Analytical Chemistry and Chromatography (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Paul Erhardt collaborates with scholars based in United States, United Kingdom and Japan. Paul Erhardt's co-authors include Jeffrey Sarver, Péter Nagy, William A. Maltese, Richard J. Gorczynski, W. Gary Anderson, Jean H. Overmeyer, Elinor H. Cantor, Ashley Young, Robert V. Smith and Christopher Trabbic and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Analytical Chemistry.

In The Last Decade

Paul Erhardt

111 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Erhardt United States 28 901 816 217 212 167 113 2.3k
Patrick S. Callery United States 24 969 1.1× 412 0.5× 181 0.8× 303 1.4× 236 1.4× 94 2.4k
A. Samuni Israel 32 1.2k 1.3× 725 0.9× 261 1.2× 118 0.6× 102 0.6× 76 3.6k
Donald T. Witiak United States 21 933 1.0× 873 1.1× 248 1.1× 215 1.0× 146 0.9× 149 2.3k
Islam Ullah Khan Pakistan 30 1.0k 1.2× 841 1.0× 293 1.4× 367 1.7× 368 2.2× 343 3.3k
Robert Martino France 32 1.0k 1.2× 476 0.6× 530 2.4× 180 0.8× 514 3.1× 119 3.1k
Brigid M. Hoey United Kingdom 19 1.0k 1.2× 485 0.6× 199 0.9× 154 0.7× 40 0.2× 30 2.9k
Shunji Kato Japan 32 1.1k 1.2× 535 0.7× 314 1.4× 74 0.3× 222 1.3× 186 3.5k
Michael D. Threadgill United Kingdom 36 1.6k 1.8× 1.1k 1.3× 688 3.2× 249 1.2× 193 1.2× 167 3.8k
Bernd Clement Germany 31 1.2k 1.4× 784 1.0× 580 2.7× 166 0.8× 93 0.6× 160 3.5k
Françoise Nepveu France 28 830 0.9× 438 0.5× 336 1.5× 105 0.5× 135 0.8× 90 2.4k

Countries citing papers authored by Paul Erhardt

Since Specialization
Citations

This map shows the geographic impact of Paul Erhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Erhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Erhardt more than expected).

Fields of papers citing papers by Paul Erhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Erhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Erhardt. The network helps show where Paul Erhardt may publish in the future.

Co-authorship network of co-authors of Paul Erhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Erhardt. A scholar is included among the top collaborators of Paul Erhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Erhardt. Paul Erhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Dong Hyun, et al.. (2021). Synthesis and Evaluation of PPARδ Agonists That Promote Osteogenesis in a Human Mesenchymal Stem Cell Culture and in a Mouse Model of Human Osteoporosis. Journal of Medicinal Chemistry. 64(10). 6996–7032. 6 indexed citations
3.
Liu, Shi‐He, Juehua Yu, Justin F. Creeden, et al.. (2020). Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma. Cancer Letters. 491. 97–107. 18 indexed citations
4.
Wang, Yunmei, Huiyun Gao, Can Shi, et al.. (2017). Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα. Nature Communications. 8(1). 15559–15559. 127 indexed citations
5.
Trabbic, Christopher, et al.. (2016). Synthesis and biological evaluation of isomeric methoxy substitutions on anti-cancer indolyl-pyridinyl-propenones: Effects on potency and mode of activity. European Journal of Medicinal Chemistry. 122. 79–91. 30 indexed citations
6.
Malik, Neha, et al.. (2013). Practical synthesis of a chromene analog for use as a retinoic acid receptor alpha antagonist lead compound. European Journal of Medicinal Chemistry. 63. 104–108. 3 indexed citations
7.
Fang, Lei, et al.. (2010). Determination of esmolol and metabolite enantiomers within human plasma using chiral column chromatography. Journal of Chromatography B. 878(26). 2449–2452. 6 indexed citations
8.
Mauro, Vincent F., et al.. (2003). Impact of Ginkgo Biloba on the Pharmacokinetics of Digoxin. American Journal of Therapeutics. 10(4). 247–251. 39 indexed citations
10.
Erhardt, Paul, John G. Topliss, Per Lindberg, et al.. (2001). La Química Farmaceútica en el desarrollo de los pueblos, biodiversidad y productos naturales. 26–31.
11.
Faghihi, J., et al.. (2001). Reproducibility of the high-performance liquid chromatographic fingerprints obtained from two soybean cultivars and a selected progeny. Journal of Chromatography A. 915(1-2). 61–74. 14 indexed citations
13.
Sarver, Jeffrey, Donald B. White, Paul Erhardt, & K Bachmann. (1997). Estimating xenobiotic half-lives in humans from rat data: influence of log P.. Environmental Health Perspectives. 105(11). 1204–1209. 25 indexed citations
14.
Bihovsky, Ron, et al.. (1995). Hydroxamic Acids as Potent Inhibitors of Endothelin-Converting Enzyme from Human Bronchiolar Smooth Muscle. Journal of Medicinal Chemistry. 38(12). 2119–2129. 32 indexed citations
15.
Lampe, John W., et al.. (1993). (Imidazolylphenyl)pyrrol-2-one inhibitors of cardiac cAMP phosphodiesterase. Journal of Medicinal Chemistry. 36(8). 1041–1047. 52 indexed citations
16.
Shaw, Kenneth J., et al.. (1992). Cardiotonic agents. 7. Prodrug derivatives of 4-ethyl-1,3-dihydro-5-[4-(2-methyl-1H-imidazol-1-yl)benzoyl]-2H-imidazol-2-one. Journal of Medicinal Chemistry. 35(7). 1267–1272. 17 indexed citations
17.
Lampe, John W., et al.. (1989). Heterocyclic analogs of benzamide antiarrhythmic agents. Journal of Medicinal Chemistry. 32(3). 688–693. 3 indexed citations
18.
Erhardt, Paul, et al.. (1989). Cardiotonic agents. 5. Fragments from the heterocycle-phenyl-imidazole pharmacophore. Journal of Medicinal Chemistry. 32(6). 1173–1176. 21 indexed citations
19.
Erhardt, Paul, et al.. (1988). Cardiotonic agents. 3. A topographical model of the cardiac cAMP phosphodiesterase receptor.. Molecular Pharmacology. 33(1). 1–13. 34 indexed citations
20.
Topiol, Sid, Michael Sabio, & Paul Erhardt. (1988). Theoretical investigations of methanesulphonamide as a hydroxy group equivalent in drugs. Examples from possible β-adrenergic agents and analysis of computational methods. Journal of the Chemical Society Perkin Transactions 2. 437–442. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026